JP2015533790A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015533790A5 JP2015533790A5 JP2015530375A JP2015530375A JP2015533790A5 JP 2015533790 A5 JP2015533790 A5 JP 2015533790A5 JP 2015530375 A JP2015530375 A JP 2015530375A JP 2015530375 A JP2015530375 A JP 2015530375A JP 2015533790 A5 JP2015533790 A5 JP 2015533790A5
- Authority
- JP
- Japan
- Prior art keywords
- deficiency
- mitochondrial
- syndrome
- pharmaceutical composition
- respiratory chain
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 230000007812 deficiency Effects 0.000 claims 13
- 230000035806 respiratory chain Effects 0.000 claims 9
- 239000008194 pharmaceutical composition Substances 0.000 claims 8
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 7
- 230000002265 prevention Effects 0.000 claims 6
- 208000006136 Leigh Disease Diseases 0.000 claims 5
- 208000035475 disorder Diseases 0.000 claims 5
- 230000002438 mitochondrial effect Effects 0.000 claims 5
- 208000011580 syndromic disease Diseases 0.000 claims 5
- 208000002155 Cytochrome-c Oxidase Deficiency Diseases 0.000 claims 4
- 208000017507 Leigh syndrome Diseases 0.000 claims 4
- 206010058799 Mitochondrial encephalomyopathy Diseases 0.000 claims 4
- 208000012268 mitochondrial disease Diseases 0.000 claims 3
- 208000023434 Alpers-Huttenlocher syndrome Diseases 0.000 claims 2
- 206010003591 Ataxia Diseases 0.000 claims 2
- 208000031229 Cardiomyopathies Diseases 0.000 claims 2
- 206010058892 Carnitine deficiency Diseases 0.000 claims 2
- 208000004986 Diffuse Cerebral Sclerosis of Schilder Diseases 0.000 claims 2
- 208000024412 Friedreich ataxia Diseases 0.000 claims 2
- 108700006159 Long-chain acyl-CoA dehydrogenase deficiency Proteins 0.000 claims 2
- 108700000232 Medium chain acyl CoA dehydrogenase deficiency Proteins 0.000 claims 2
- 201000002169 Mitochondrial myopathy Diseases 0.000 claims 2
- 208000014844 Mitochondrial neurogastrointestinal encephalomyopathy Diseases 0.000 claims 2
- 108700017825 Short chain Acyl CoA dehydrogenase deficiency Proteins 0.000 claims 2
- 108700005875 X-linked Creatine deficiency Proteins 0.000 claims 2
- 201000010099 disease Diseases 0.000 claims 2
- 230000004064 dysfunction Effects 0.000 claims 2
- 208000006443 lactic acidosis Diseases 0.000 claims 2
- 208000004687 long chain acyl-CoA dehydrogenase deficiency Diseases 0.000 claims 2
- 208000005548 medium chain acyl-CoA dehydrogenase deficiency Diseases 0.000 claims 2
- 201000011540 mitochondrial DNA depletion syndrome 4a Diseases 0.000 claims 2
- 230000004065 mitochondrial dysfunction Effects 0.000 claims 2
- 230000004898 mitochondrial function Effects 0.000 claims 2
- 230000000750 progressive effect Effects 0.000 claims 2
- 208000001392 short chain acyl-CoA dehydrogenase deficiency Diseases 0.000 claims 2
- 208000016505 systemic primary carnitine deficiency disease Diseases 0.000 claims 2
- 201000010866 very long chain acyl-CoA dehydrogenase deficiency Diseases 0.000 claims 2
- 102100039358 3-hydroxyacyl-CoA dehydrogenase type-2 Human genes 0.000 claims 1
- 201000007993 AGAT deficiency Diseases 0.000 claims 1
- 102000003966 Alpha-1-microglobulin Human genes 0.000 claims 1
- 101800001761 Alpha-1-microglobulin Proteins 0.000 claims 1
- 108700009893 Arginine-Glycine Amidinotransferase Deficiency Proteins 0.000 claims 1
- 206010003694 Atrophy Diseases 0.000 claims 1
- 208000005359 Carnitine palmitoyl transferase 1A deficiency Diseases 0.000 claims 1
- 201000002929 Carnitine palmitoyltransferase II deficiency Diseases 0.000 claims 1
- 206010008025 Cerebellar ataxia Diseases 0.000 claims 1
- 208000010354 Coenzyme Q10 deficiency Diseases 0.000 claims 1
- 102000008013 Electron Transport Complex I Human genes 0.000 claims 1
- 108010089760 Electron Transport Complex I Proteins 0.000 claims 1
- 102000015782 Electron Transport Complex III Human genes 0.000 claims 1
- 108010024882 Electron Transport Complex III Proteins 0.000 claims 1
- 101000804964 Homo sapiens DNA polymerase subunit gamma-1 Proteins 0.000 claims 1
- 101001083553 Homo sapiens Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial Proteins 0.000 claims 1
- 101000841267 Homo sapiens Long chain 3-hydroxyacyl-CoA dehydrogenase Proteins 0.000 claims 1
- 101000595929 Homo sapiens POLG alternative reading frame Proteins 0.000 claims 1
- 208000032242 L-Arginine:glycine amidinotransferase deficiency Diseases 0.000 claims 1
- 102100029107 Long chain 3-hydroxyacyl-CoA dehydrogenase Human genes 0.000 claims 1
- 108010027062 Long-Chain Acyl-CoA Dehydrogenase Proteins 0.000 claims 1
- 102000018653 Long-Chain Acyl-CoA Dehydrogenase Human genes 0.000 claims 1
- 102100021644 Long-chain specific acyl-CoA dehydrogenase, mitochondrial Human genes 0.000 claims 1
- 206010059396 Mitochondrial DNA depletion Diseases 0.000 claims 1
- 208000001769 Multiple Acyl Coenzyme A Dehydrogenase Deficiency Diseases 0.000 claims 1
- 208000036572 Myoclonic epilepsy Diseases 0.000 claims 1
- 102000006746 NADH Dehydrogenase Human genes 0.000 claims 1
- 108010086428 NADH Dehydrogenase Proteins 0.000 claims 1
- 102000004316 Oxidoreductases Human genes 0.000 claims 1
- 108090000854 Oxidoreductases Proteins 0.000 claims 1
- 102100035196 POLG alternative reading frame Human genes 0.000 claims 1
- 206010033799 Paralysis Diseases 0.000 claims 1
- 208000013234 Pearson syndrome Diseases 0.000 claims 1
- 208000002009 Pyruvate Dehydrogenase Complex Deficiency Disease Diseases 0.000 claims 1
- 208000021886 Pyruvate carboxylase deficiency Diseases 0.000 claims 1
- 206010057430 Retinal injury Diseases 0.000 claims 1
- 208000007014 Retinitis pigmentosa Diseases 0.000 claims 1
- 208000006011 Stroke Diseases 0.000 claims 1
- 102000019259 Succinate Dehydrogenase Human genes 0.000 claims 1
- 108010012901 Succinate Dehydrogenase Proteins 0.000 claims 1
- 208000034091 X-linked creatine transporter deficiency Diseases 0.000 claims 1
- 230000037444 atrophy Effects 0.000 claims 1
- 201000004010 carnitine palmitoyltransferase I deficiency Diseases 0.000 claims 1
- 208000037887 cell injury Diseases 0.000 claims 1
- 230000001684 chronic effect Effects 0.000 claims 1
- 201000002997 creatine transporter deficiency Diseases 0.000 claims 1
- 208000026615 cytochrome-c oxidase deficiency disease Diseases 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 229940079593 drug Drugs 0.000 claims 1
- 230000000694 effects Effects 0.000 claims 1
- 230000007613 environmental effect Effects 0.000 claims 1
- 208000030533 eye disease Diseases 0.000 claims 1
- 239000000835 fiber Substances 0.000 claims 1
- 208000023692 inborn mitochondrial myopathy Diseases 0.000 claims 1
- 238000012423 maintenance Methods 0.000 claims 1
- 210000003205 muscle Anatomy 0.000 claims 1
- 230000035772 mutation Effects 0.000 claims 1
- 201000001119 neuropathy Diseases 0.000 claims 1
- 230000007823 neuropathy Effects 0.000 claims 1
- 108010007425 oligomycin sensitivity conferring protein Proteins 0.000 claims 1
- 210000001328 optic nerve Anatomy 0.000 claims 1
- 238000007254 oxidation reaction Methods 0.000 claims 1
- 208000033808 peripheral neuropathy Diseases 0.000 claims 1
- 201000006473 pyruvate decarboxylase deficiency Diseases 0.000 claims 1
- 208000015445 pyruvate dehydrogenase deficiency Diseases 0.000 claims 1
- 238000011084 recovery Methods 0.000 claims 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DKPA201270538 | 2012-09-05 | ||
| DKPA201270538 | 2012-09-05 | ||
| DKPA201270557 | 2012-09-12 | ||
| DKPA201270557 | 2012-09-12 | ||
| PCT/EP2013/068270 WO2014037390A1 (en) | 2012-09-05 | 2013-09-04 | Alpha-1-microglobulin for use in the treatment of mitochondria-related diseases |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018157394A Division JP2018203756A (ja) | 2012-09-05 | 2018-08-24 | ミトコンドリア関連疾患の治療に使用するためのα−１−ミクログロブリン |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2015533790A JP2015533790A (ja) | 2015-11-26 |
| JP2015533790A5 true JP2015533790A5 (enExample) | 2016-09-08 |
Family
ID=49162118
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015530375A Pending JP2015533790A (ja) | 2012-09-05 | 2013-09-04 | ミトコンドリア関連疾患の治療に使用するためのα−１−ミクログロブリン |
| JP2018157394A Pending JP2018203756A (ja) | 2012-09-05 | 2018-08-24 | ミトコンドリア関連疾患の治療に使用するためのα−１−ミクログロブリン |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018157394A Pending JP2018203756A (ja) | 2012-09-05 | 2018-08-24 | ミトコンドリア関連疾患の治療に使用するためのα−１−ミクログロブリン |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US10226507B2 (enExample) |
| EP (1) | EP2900254B1 (enExample) |
| JP (2) | JP2015533790A (enExample) |
| KR (1) | KR20150047510A (enExample) |
| CN (1) | CN104661673A (enExample) |
| AU (1) | AU2013311714C1 (enExample) |
| BR (1) | BR112015003957A2 (enExample) |
| CA (1) | CA2881321A1 (enExample) |
| DK (1) | DK2900254T3 (enExample) |
| EA (1) | EA028963B1 (enExample) |
| ES (1) | ES2599034T3 (enExample) |
| HR (1) | HRP20161364T1 (enExample) |
| HU (1) | HUE030559T2 (enExample) |
| IN (1) | IN2015DN00515A (enExample) |
| MX (1) | MX357656B (enExample) |
| NZ (1) | NZ629621A (enExample) |
| PL (1) | PL2900254T3 (enExample) |
| PT (1) | PT2900254T (enExample) |
| SG (1) | SG11201500669SA (enExample) |
| WO (1) | WO2014037390A1 (enExample) |
| ZA (1) | ZA201500547B (enExample) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2016204360A (ja) * | 2015-02-25 | 2016-12-08 | エー１エム ファーマ エービーＡ１Ｍ Ｐｈａｒｍａ ＡＢ | 放射性核種療法における腎臓の保護に用いるためのアルファ−１−ミクログロブリン |
| EP3419647A1 (en) * | 2016-02-25 | 2019-01-02 | A1M Pharma AB | Alpha-1-microglobulin for use in the protection of kidneys in connection with use of contrast media |
| BR112018068522A2 (pt) * | 2016-03-18 | 2019-01-22 | A1M Pharma Ab | novas proteínas derivadas de alfa-1-microglobulina e seu uso |
| GB2566516A (en) | 2017-09-15 | 2019-03-20 | Univ Oxford Innovation Ltd | Electrochemical recognition and quantification of cytochrome c oxidase expression in bacteria |
| CN109867717A (zh) * | 2019-04-01 | 2019-06-11 | 山西瑞亚力生物技术有限公司 | 一种血浆中α1微球蛋白的提取方法 |
| CN110452980B (zh) * | 2019-09-23 | 2023-07-28 | 武汉儿童医院 | 一种线粒体脑肌病诊断试剂盒及应用 |
| WO2021062007A1 (en) * | 2019-09-25 | 2021-04-01 | Cytegen Corp. | Treatment of mitochondrial deficits and age-related diseases using blood products |
| CN115575646B (zh) * | 2022-11-21 | 2023-04-28 | 四川大学华西医院 | 一种代谢标志物组在制备预测癫痫发作的试剂盒中的用途 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20060110306A (ko) * | 2003-11-26 | 2006-10-24 | 사노피-아벤티스 도이칠란트 게엠베하 | 상승된 심혈관 위험에 대한 징후로서 세뇨관성 단백뇨 |
| WO2008098734A1 (en) * | 2007-02-12 | 2008-08-21 | Stefan Hansson | Diagnosis and treatment of preeclampsia |
| WO2009098682A2 (en) * | 2008-02-04 | 2009-08-13 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Methods and compositions for treatment of mitochondrial disorders |
| EP2313106B1 (en) | 2008-07-18 | 2016-03-30 | A1M Pharma AB | Medical use of the radical scavenger and antioxidant alpha-1-microglobulin |
-
2013
- 2013-09-04 ES ES13759995.7T patent/ES2599034T3/es active Active
- 2013-09-04 CN CN201380043567.0A patent/CN104661673A/zh active Pending
- 2013-09-04 HR HRP20161364TT patent/HRP20161364T1/hr unknown
- 2013-09-04 AU AU2013311714A patent/AU2013311714C1/en not_active Ceased
- 2013-09-04 MX MX2015002604A patent/MX357656B/es active IP Right Grant
- 2013-09-04 SG SG11201500669SA patent/SG11201500669SA/en unknown
- 2013-09-04 CA CA2881321A patent/CA2881321A1/en not_active Abandoned
- 2013-09-04 IN IN515DEN2015 patent/IN2015DN00515A/en unknown
- 2013-09-04 NZ NZ629621A patent/NZ629621A/en not_active IP Right Cessation
- 2013-09-04 KR KR1020157005748A patent/KR20150047510A/ko not_active Ceased
- 2013-09-04 JP JP2015530375A patent/JP2015533790A/ja active Pending
- 2013-09-04 WO PCT/EP2013/068270 patent/WO2014037390A1/en not_active Ceased
- 2013-09-04 BR BR112015003957A patent/BR112015003957A2/pt not_active Application Discontinuation
- 2013-09-04 PT PT137599957T patent/PT2900254T/pt unknown
- 2013-09-04 US US14/423,260 patent/US10226507B2/en not_active Expired - Fee Related
- 2013-09-04 HU HUE13759995A patent/HUE030559T2/en unknown
- 2013-09-04 PL PL13759995T patent/PL2900254T3/pl unknown
- 2013-09-04 EA EA201590503A patent/EA028963B1/ru not_active IP Right Cessation
- 2013-09-04 EP EP13759995.7A patent/EP2900254B1/en not_active Not-in-force
- 2013-09-04 DK DK13759995.7T patent/DK2900254T3/en active
-
2015
- 2015-01-23 ZA ZA2015/00547A patent/ZA201500547B/en unknown
-
2018
- 2018-08-24 JP JP2018157394A patent/JP2018203756A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2015533790A5 (enExample) | ||
| HRP20161364T1 (hr) | Alfa-1-mikroglobulin za uporabu za liječenje bolesti povezanih s mitohondrijima | |
| Pinto et al. | Mitochondrial genome changes and neurodegenerative diseases | |
| JP2014513036A5 (enExample) | ||
| EA201400686A1 (ru) | ПРИМЕНЕНИЕ СОЕДИНЕНИЙ ТИПА СТРОБИЛУРИНОВ ДЛЯ БОРЬБЫ С ФИТОПАТОГЕННЫМИ ГРИБАМИ, УСТОЙЧИВЫМИ К ИНГИБИТОРАМ Qo | |
| BR112015001371A2 (pt) | composição farmacêutica ou nutracêutica resistente ao suco gástrico com resistência contra a influência de etanol | |
| BR112014014334A2 (pt) | máquina de lavar louça | |
| CY1123367T1 (el) | Μεθοδοι και συνθεσεις για τη ρυθμιση της εκφρασης της απολιποπρωτεϊνης (α) | |
| Hua et al. | Product design strategies in a manufacturer–retailer distribution channel | |
| Anokhina et al. | Racah coefficients and extended HOMFLY polynomials for all 5-, 6-and 7-strand braids | |
| JP2016515526A5 (enExample) | ||
| BR112017025045A2 (pt) | plx-8394 ou plx-7904 para uso no tratamento de doenças relacionadas a braf-v600 | |
| JP2016520621A5 (enExample) | ||
| EA201490919A1 (ru) | Производные бетулина | |
| WO2016075326A3 (en) | Materials and methods for pufa production, and pufa-containing compositions | |
| MX2021005590A (es) | Ácidos nucleicos para inhibir la expresión de lpa en una célula. | |
| BR112014003469A2 (pt) | microrganismo com uma maior produtividade de l-valina e método para a produção de l-valina utilizando o mesmo | |
| BR112014013811A8 (pt) | sistema mecânico que compreende uma peça de desgaste e um suporte, e balde que compreende pelo menos tal sistema mecânico | |
| JP2016514697A5 (enExample) | ||
| PL399794A1 (pl) | Sposób i zespól do nierównomiernego przekazywania kapsulek | |
| Jerome et al. | Regulation of mitochondrial function by forkhead transcription factors | |
| BR112016020278A8 (pt) | Derivados de 1,2-diidro-3h pirrolo[1,2- c]imidazol-3-ona antibacterianos | |
| BR112017023264A2 (pt) | composição | |
| DK3129392T3 (da) | Triterpenoider med hiv-modningsinhiberende aktivitet, substitueret i position 3 af en ikke-aromatisk ring som bærer en haloalkylsubstituent | |
| TR201910319T4 (tr) | Şasi sistemine yönelik palet zinciri düzeneği. |